Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaques

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1218-1226

  Embers, Monica E ^a   Hasenkampf, Nicole R ^a   Jacobs, Mary B ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; DOXYCYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OUTER SURFACE PROTEIN A; PROTEIN BBK32; PROTEIN DBPA; PROTEIN OPPA 2; PROTEIN OSPC; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG RESPONSE; IMMUNOASSAY; LONGITUDINAL STUDY; LYME DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; HUMANS; LONGITUDINAL STUDIES; LYME DISEASE; MACACA MULATTA; MALE;

EID: 84864540383     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00228-12     Document Type: Article

References (46)

1. Aguero-Rosenfeld M, et al. 1996. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34:1-9. (Pubitemid 126506881)
2. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18:484-509. (Pubitemid 40995113)
3. Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:173-181. (Pubitemid 29021645)
4. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. 1994. Lyme disease: an infectious and postinfectious syndrome. J. Rheumatol. 21:454-461. (Pubitemid 24102829)
5. Bacon RM, et al. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using wholecell lysates. J. Infect. Dis. 187:1187-1199. (Pubitemid 36438958)
6. Bacon RM, Kugeler KJ, Mead PS. 2008. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ. 57:1-9.
7. Barbour AG, et al. 2008. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect. Immun. 76:3374-3389.
8. Barthold SW, et al. 2010. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob. Agents Chemother. 54:643-651.
9. Barthold SW, Hodzic E, Tunev S, Feng S. 2006. Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect. Immun. 74:4817-4825. (Pubitemid 44157269)
10. Bockenstedt L, Mao J, Hodzic E, Barthold S, Fish D. 2002. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. 186:1430-1437. (Pubitemid 35286110)
11. Brown EL, Kim JH, Reisenbichler ES, Höök M. 2005. Multicomponent Lyme vaccine: three is not a crowd. Vaccine 23:3687-3696. (Pubitemid 40692414)
12. Chandra A, Wormser GP, Marques AR, Latov N, Alaedini A. 2011. Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin. Vaccine Immunol. 18:767-771.
13. Crother TR, et al. 2004. Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect. Immun. 72:5063-5072. (Pubitemid 39223390)
14. Das S, et al. 1996. Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res. Microbiol. 147:739-751. (Pubitemid 26408351)
15. Embers ME, et al. 2012. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 7:e29914. doi:10.1371/journal.pone.0029914.
16. Embers ME, Jacobs MB, Johnson BJ, Philipp MT. 2007. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule. Clin. Vaccine Immunol. 14:931-936.
17. Engstrom SM, Shoop E, Johnson RC. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
18. Goettner G, et al. 2005. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulinG(IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J. Clin. Microbiol. 43:3602-3609. (Pubitemid 41129635)
19. Grimm D, et al. 2004. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U. S. A. 101:3142-3147. (Pubitemid 38327748)
20. Hagman KE, et al. 2000. Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect. Immun. 68:4759-4764. (Pubitemid 30497751)
21. Hanson MS, et al. 1998. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66:2143-2153. (Pubitemid 28194114)
22. Hilton E, Tramontano A, DeVoti J, Sood S. 1997. Temporal study of immunoglobinMseroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J. Clin. Microbiol. 35:774-776. (Pubitemid 27083882)
23. Ivanova L, et al. 2009. Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design. Clin. Immunol. 132:393-400.
24. Jobe DA, et al. 2008. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin. Vaccine Immunol. 15:981-985. (Pubitemid 351966998)
25. Jungblut PR, Grabher G, Stöffler G. 1999. Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis. Electrophoresis 20:3611-3622. (Pubitemid 30007259)
26. Kalish RA, Leong JM, Steere AC. 1995. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63:2228-2235.
27. Kornacki JA, Oliver DB. 1998. Lyme disease-causing Borrelia species encode multiple lipoproteins homologous to peptide-binding proteins of ABC-type transporters. Infect. Immun. 66:4115-4122. (Pubitemid 28402680)
28. Liang FT, Jacobs MB, Bowers LC, Philipp MT. 2002. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J. Exp. Med. 195:415-422. (Pubitemid 34461295)
29. Magnarelli LA, et al. 2001. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J. Med. Microbiol. 50:889-895. (Pubitemid 32905217)
30. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. 2004. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol. 11:924-929. (Pubitemid 39280600)
31. Nowalk AJ, Gilmore RD, Carroll JA. 2006. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun. 74:3864-3873. (Pubitemid 43993317)
32. Nyman D, et al. 2006. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Clin. Microbiol. Infect. 12:496-497.
33. Pachner AR, et al. 2002. Humoral immune response associated with Lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin. Diagn. Lab. Immunol. 9:1348-1355. (Pubitemid 35283303)
34. Panelius J, et al. 2002. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J. Med. Microbiol. 51:731-739.
35. Panelius J, et al. 2003. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J. Neurol. 250:1318-1327. (Pubitemid 37456892)
36. Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS. 2003. C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J. Clin. Microbiol. 41:4955-4960. (Pubitemid 37429901)
37. Philipp MT, et al. 2005. A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin. Diagn. Lab Immunol. 12:1069-1074. (Pubitemid 41324538)
38. Piesman J, Hicks TC, Sinsky RJ, Obiri G. 1987. Simultaneous transmission of Borrelia burgdorferi and Babesia microti by individual nymphal Ixodes dammini ticks. J. Clin. Microbiol. 25:2012-2013. (Pubitemid 17149291)
39. Purser JE, Norris SJ. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 97:13865-13870.
40. Schwan TG, Piesman J. 2000. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38:382-388. (Pubitemid 30043321)
41. Tanabe M, et al. 2006. The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect. Immun. 74:3687-3691. (Pubitemid 43794564)
42. Tunev SS, et al. 2011. Lymphoadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B cell activation. PLoS Pathog. 7:e1002066. doi:10.1371/journal.ppat.1002066.
43. Wang X-G, Lin B, Kidder JM, Telford S, Hu LT. 2002. Effects of environmental changes on expression of the oligopeptide permease (opp) genes of Borrelia burgdorferi. J. Bacteriol. 184:6198-6206. (Pubitemid 35265901)
44. Wilske B, et al. 1994. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med. Microbiol. Immunol. 183:43-59. (Pubitemid 24078950)
45. Wilske B, Fingerle V, Schulte-Spechtel U. 2007. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49:13-21. (Pubitemid 46160581)
46. Yang M, Johnson A, Murphy TF. 2011. Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Infect. Immun. 79:846-857.